logo
Select company
Select metric
$ 0Gross Profit
VS
Market
3
Sector
4
Industry
3
History
-
$ 11.25Close
$ 8.84 - $ 12.53 52-Week Range
Ticker Information

Ticker

BBOT

Company Name

BRIDGEBIO ONCOLOGY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BRIDGEBIO ONCOLOGY THERAPEUTICS INC - Gross Profit Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BBOT - GP Historical data
DateGross Profit
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
12/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BRIDGEBIO ONCOLOGY THERAPEUTICS INC's latest trailing twelve months (TTM) GP stands at $ 0.
  • Over the past 5 years, BRIDGEBIO ONCOLOGY THERAPEUTICS INC's average GP has been $ 0.
  • The median GP for BRIDGEBIO ONCOLOGY THERAPEUTICS INC during this period was $ 0
  • BRIDGEBIO ONCOLOGY THERAPEUTICS INC reached its highest GP over the past 5 years at $ 0.
  • The lowest GP recorded by BRIDGEBIO ONCOLOGY THERAPEUTICS INC in the same timeframe $ 0

Definition of Gross Profit

[Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].

BBOT - Gross Profit, Last 5 years

$ 0

Minimum

Dec 31, 2023

$ 0

Maximum

Dec 31, 2023

$ 0

Average

$ 0

Median

GP Benchmark Analysis

The chart above depicts the distribution of GP for companies in the Total Stock Market. The average GP of the companies is $ 245.12M with a standard deviation of $ 328.2M.
The following table provides additional summary stats:
GP in the Market:
filtered constituents3.34K
min$ -790.38M
max$ 1.32B
average$ 245.12M
median$ 92.73M
std$ 328.2M